Valuation : BioNTech SE

Market Cap 21.33B 24.82B 20.1B 18.31B 34.25B 2,361B 34.37B 238B 91.9B 1,205B 93.14B 91.12B 3,809B P/E 2026 *
-14.8x
P/E 2027 * -15.5x
Enterprise Value 9.96B 11.59B 9.38B 8.55B 15.99B 1,102B 16.05B 111B 42.91B 563B 43.49B 42.55B 1,778B EV / Sales 2026 *
5.51x
EV / Sales 2027 * 6.23x
Free-Float
96.06%
Yield 2026 *
-
Yield 2027 * -
1 day+0.53%
1 week-3.74%
Current month-3.42%
1 month+4.76%
3 months+14.77%
6 months-3.32%
Current year+3.08%
1 week 96.87
Extreme 96.87
105.15
1 month 90.52
Extreme 90.52
120.33
Current year 79.52
Extreme 79.52
124
1 year 79.52
Extreme 79.52
124
3 years 76.53
Extreme 76.5301
131.49
5 years 76.53
Extreme 76.5301
374.85
10 years 12.52
Extreme 12.525
464
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 01/01/2018
Chief Executive Officer 61 02/06/2008
Director of Finance/CFO - 01/07/2025
Director TitleAgeSince
Chairman 56 02/06/2008
Director/Board Member 69 02/06/2008
Director/Board Member 65 01/01/2018
Date Insider Type Main position Quantity % Market Cap. Importance
12/5/26 Free

Chief Operating Officer

22,655 0.0094%
12/5/26 Free

Chief Financial Officer

33,982 0.0141%
12/5/26 Free

Head of Human Resources

18,879 0.0078%
Change 5-day change 1-year change 3-year change Capi.($)
-0.54%-3.74%-4.41%-18.31% 24.78B
-0.94%+0.31%+40.04%+103.25% 69.19B
-0.07%-2.37%+33.44%+78.50% 62.97B
+3.13%+6.00%-12.19%+390.48% 27.27B
-0.93%-1.29%+25.30%+16.70% 25.8B
-1.43%-0.61%+22.71%-19.01% 20.11B
-4.27%+2.67%+219.02%+362.48% 18.47B
-1.43%-1.80%-8.64%+537.09% 14.88B
+1.14%+2.53%+54.76%+163.82% 14.29B
+1.50%+23.87%-9.80%+1,038.96% 13.79B
Average -0.28%+1.93%+36.02%+265.40% 29.15B
Weighted average by Cap. -0.30%+0.32%+34.67%+184.12%

Financials

2026 *2027 *
Net sales 1.81B 2.1B 1.7B 1.55B 2.9B 200B 2.91B 20.15B 7.79B 102B 7.89B 7.72B 323B 1.81B 2.11B 1.71B 1.56B 2.91B 201B 2.92B 20.22B 7.81B 102B 7.92B 7.75B 324B
Net income -1.38B -1.6B -1.3B -1.18B -2.21B -153B -2.22B -15.37B -5.94B -77.86B -6.02B -5.89B -246B -1.31B -1.52B -1.23B -1.12B -2.1B -145B -2.11B -14.6B -5.64B -73.95B -5.72B -5.59B -234B
Net Debt -11.37B -13.23B -10.71B -9.76B -18.26B -1,258B -18.32B -127B -48.99B -642B -49.65B -48.58B -2,030B -10.03B -11.67B -9.45B -8.61B -16.11B -1,110B -16.17B -112B -43.23B -567B -43.81B -42.86B -1,791B
Logo BioNTech SE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Employees
7,807
Date Price Change Volume
09/09/26 US$98.13 -0.54% 706,191
08/09/26 US$98.66 -4.92% 1,127,495
04/09/26 US$103.76 +0.86% 626,059
03/09/26 US$102.88 -0.90% 1,180,896
02/09/26 US$103.81 +1.83% 753,654
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
84.83EUR
Average target price
102.47EUR
Spread / Average Target
+20.79%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BNTX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!